Mercer Global Advisors
CATX icon

Mercer Global Advisors’s Perspective Therapeutics CATX Stock Holding History

Mercer Global Advisors’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$75.4K Sell
22,118
-151
-0.7% -$570 ﹤0.01% 3477
2026
Q1 		$92.9K Sell
22,269
-5,435
-20% -$23K ﹤0.01% 3035
2025
Q4 		$76.2K Sell
27,704
-1,571
-5% -$4.48K ﹤0.01% 2750
2025
Q3 		$100K Buy
29,275
+13,168
+82% +$48K ﹤0.01% 2513
2025
Q2 		$55.4K Buy
16,107
+17
+0.1% +$45 ﹤0.01% 2193
2025
Q1 		$34.3K Buy
16,090
+2
+0% +$6 ﹤0.01% 2117
2024
Q4 		$51.3K Buy
+16,088
New +$131K ﹤0.01% 2083
2024
Q2 		– Hold
0
– -$1.44M – 1971
2024
Q1 		– Hold
0
– – – 821

Other funds holding CATX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Mercer Global Advisors's CATX Position: Q2 2026 in Review

Mercer Global Advisors reduced its Perspective Therapeutics (CATX) stake by 0.68% in Q2 2026, selling an estimated $570 and leaving 22,118 shares worth $75.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3477.

Mercer Global Advisors first reported a position in CATX in Q4 2024 and has held it in 7 quarters since. The position peaked at $100K in Q3 2025. 131 funds tracked by Wall St. Rank hold CATX as of Q2 2026.

  • Mercer Global Advisors held 22,118 shares of Perspective Therapeutics worth $75.4K as of Q2 2026.
  • Mercer Global Advisors sold 151 Perspective Therapeutics shares in Q2 2026, an estimated $570.
  • Perspective Therapeutics made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #3477 holding.
  • Mercer Global Advisors first reported a position in Perspective Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • Mercer Global Advisors's Perspective Therapeutics position peaked at $100K in Q3 2025.
  • 131 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.